BeyondSpring Pharmaceuticals, Inc.

Climate Impact & Sustainability Data (2022, 2023)

Reduced waste in labs by implementing reusable glassware and recycling initiatives.
Minimized drug screening efforts and used state-of-the-art equipment for greener strategies.
Reduced value-chain emissions by seeking life science suppliers with similar environmental visions and standards.
Installed LED lighting, replaced fans and pumps with VFDs, and replaced air dampers in office building.
Implemented hybrid work model, reducing office energy consumption by more than 50%.

Maintained commitment to charitable giving (American Red Cross, St. Jude Children's Research Hospital, etc.).
Fostered a work environment with notable percentages of female employees and minority ethnicities (as of June 2023: 25% female management, 43% female board committees, 50% other minority ethnicities in management).
Offered wellness initiatives (health and wellness program, flexible work arrangements).
Implemented semi-yearly and year-end performance reviews and mentorship programs.
Offered regular unconscious bias and diversity training.

Established a Code of Ethics and Business Conduct.
Established three standing committees: Audit Committee, Compensation Committee, and Nominating & Corporate Governance Committee.
Implemented a Whistleblower Program.
Procedures and Code of Ethics in place to prohibit bribery and corruption.

Medium-term Goals:

Replacing remaining supply-and-return air dampers before 2030 (office building).

Short-term Goals:

Replacing steam hot water heaters with electric ones within two years (office building).

Limited knowledge of water consumption in New York office space.
Minimal environmental impact but recognition of risks posed by global climate change.

Close contact with building management to improve water consumption tracking in the future.
High standards when partnering with vendors to limit carbon footprint.
Collaboration with manufacturing vendor (Pii) for waste management.
Implementation of energy-saving strategies in SEED Therapeutics lab.

Supplier Audits: Periodic evaluations, reviews, and audits; qualification audits every 2 years on key suppliers.

High standards of ethical conduct, environmental protection, and human rights in procurement practices.

Reduced energy consumption in office space by more than 50% through a hybrid work model.
SEED Therapeutics implemented reusable glassware and recycling initiatives, saving hundreds of pounds of plastic consumables each fiscal quarter.
SEED Therapeutics miniaturized drug screening efforts, using state-of-the-art equipment to reduce waste.

67% of management are female.
67% of management are other minority ethnicities.
Implemented semi-yearly and year-end performance reviews for employees.
Implemented mentorship programs for employee development.
Offered wellness initiatives including a health and wellness program and flexible work arrangements.
Regular team-building activities and cross-functional project opportunities.

Close contact with building management to improve water consumption tracking in the future.
Collaboration with vendors to limit carbon footprint in an environmentally responsible way.
High standards when partnering with vendors, emphasizing shared values.

Supplier Audits: Qualification audits conducted every 2 years on key suppliers.

Suppliers are evaluated, reviewed, and audited periodically to ensure that contracted services conform to BeyondSpring quality requirements, contractual obligations and required regulatory compliance.